TRATAMIENTO DE LA ANEMIA FERROPÉNICA EN ADULTOS EN ATENCIÓN PRIMARIA: DE LA INVESTIGACIÓN AL TRATAMIENTO BASADO EN LA EVIDENCIA

Autores/as

  • Laura Leme de Araujo Rodrigues da Silva Autor/a
  • Wanderson Carlos Santos Agra Autor/a
  • Poliana Lopes Rodrigues dos Santos Autor/a
  • Bruna Ester Wickert Autor/a
  • Maria Auxiliadora Bezerra Fechine Autor/a
  • Nayara Ferreira França Autor/a
  • Álvaro Dias de Alkmin Filho Autor/a
  • Yaisel Lázaro Martínez Hernández Autor/a
  • Andre Luis Vieira Sampaio Autor/a
  • Pabllo Adelino Estevam Barbosa Autor/a
  • Barbara Pereira Pessoa Autor/a
  • Priscila Maria Menezes Uchoa Autor/a
  • Nathália Déo Gasparotto Autor/a
  • Gilson Barbosa de Liboreiro Júnior Autor/a
  • Gabriela Meireles Damaceno Autor/a

DOI:

https://doi.org/10.56238/levv16n51-039

Palabras clave:

Anemia Ferropénica, Atención Primaria de Salud, Hepcidina, Deficiencia de Hierro, Suplementación Oral de Hierro

Resumen

La anemia ferropénica es la forma más común de anemia en todo el mundo y representa un importante problema de salud pública, sobre todo en los países en desarrollo. En el contexto de la Atención Primaria de Salud (APS), el reconocimiento precoz y el manejo adecuado de la anemia ferropénica son esenciales para prevenir complicaciones clínicas y mejorar la calidad de vida de los pacientes. Este estudio pretende analizar, en base a la evidencia científica más reciente, las estrategias diagnósticas y terapéuticas más eficaces para el manejo de la anemia ferropénica en adultos dentro de la APS. Se abordan aspectos fisiopatológicos, como el papel de la hepcidina en la regulación de la homeostasis del hierro, los criterios de laboratorio para el diagnóstico diferencial y los principales abordajes terapéuticos, incluyendo la suplementación con hierro oral e intravenoso. El estudio hace hincapié en la importancia de interpretar críticamente los marcadores de laboratorio, especialmente en las afecciones inflamatorias, y subraya la necesidad de protocolos clínicos actualizados y adaptados a la realidad de la atención primaria. Se concluye que el tratamiento eficaz de la anemia ferropénica requiere un enfoque integrado, basado en la evidencia y centrado en el paciente, alineado con los principios de la atención continua e integral en APS.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

NEMETH, E.; GANZ, T. Hepcidin and iron in health and disease. Annual Review of Medicine, v. 74, p. 261–277, 2023. Disponível em: https://doi.org/10.1146/annurev-med-043021-032816. Acesso em: 7 ago. 2025.

LO, J. O. et al. The role of oral iron in the treatment of adults with iron deficiency. European Journal of Haematology, v. 110, p. 123–130, 2023. Disponível em: https://doi.org/10.1111/ejh.13892. Acesso em: 7 ago. 2025.

KOLEINI, N. et al. Ironing out mechanisms of iron homeostasis and disorders of iron deficiency. The Journal of Clinical Investigation, v. 131, e148671, 2021. Disponível em: https://doi.org/10.1172/JCI148671. Acesso em: 7 ago. 2025.

CAMASCHELLA, C. Iron-deficiency anemia. The New England Journal of Medicine, v. 372, p. 1832–1843, 2015. Disponível em: https://doi.org/10.1056/NEJMra1401038. Acesso em: 7 ago. 2025.

PEYRIN-BIROULET, L.; WILLIET, N.; CACIOUB, P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. American Journal of Clinical Nutrition, v. 102, p. 1585–1594, 2015. Disponível em: https://doi.org/10.3945/ajcn.114.103366. Acesso em: 7 ago. 2025.

DARU, J. et al. Serum ferritin as an indicator of iron status: what do we need to know? American Journal of Clinical Nutrition, v. 106, p. 1634S–1639S, 2017. Disponível em: https://doi.org/10.3945/ajcn.117.155960. Acesso em: 7 ago. 2025.

ROHR, M.; BRANDENBURG, V.; BRUNNER-LA ROCCA, H. P. How to diagnose iron deficiency in chronic disease: a review of current methods and potential marker for the outcome. European Journal of Medical Research, v. 28, p. 15, 2023. Disponível em: https://doi.org/10.1186/s40001-022-00922-6. Acesso em: 7 ago. 2025.

NAVEED, K. et al. Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: a modified Delphi study. International Journal of Laboratory Hematology, v. 45, p. 377–386, 2023. Disponível em: https://doi.org/10.1111/ijlh.14016. Acesso em: 7 ago. 2025.

MAST, A. E. et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clinical Chemistry, v. 44, p. 45–51, 1998. Disponível em: https://doi.org/10.1093/clinchem/44.1.45. Acesso em: 7 ago. 2025.

BLACKMORE, S. et al. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard. Clinical Chemistry and Laboratory Medicine, v. 46, p. 1450–1457, 2008. Disponível em: https://doi.org/10.1515/CCLM.2008.304. Acesso em: 7 ago. 2025.

SWINKELS, D. W. Iron metabolism. In: RIFAI, N. (ed.). Tietz Textbook of Laboratory Medicine. 7. ed. s.l.: Tietz, 2022. cap. 40.

WEISS, G.; GOODNOUGH, L. T. Anemia of chronic disease. The New England Journal of Medicine, v. 352, p. 1011–1023, 2005. Disponível em: https://doi.org/10.1056/NEJMra041809. Acesso em: 7 ago. 2025.

GIRELLI, D.; MARCHI, G.; CAMASCHELLA, C. Anemia in the elderly. HemaSphere, v. 2, e40, 2018. Disponível em: https://doi.org/10.1097/HS9.0000000000000040. Acesso em: 7 ago. 2025.

STAUDER, R.; VALENT, P.; THEURL, I. Anemia at older age: etiologies, clinical implications, and management. Blood, v. 131, p. 505–514, 2018. Disponível em: https://doi.org/10.1182/blood-2017-07-746446. Acesso em: 7 ago. 2025.

MARQUES, O.; WEISS, G.; MUCKENTHALER, M. U. The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation. Blood, v. 140, p. 2011–2023, 2022. Disponível em: https://doi.org/10.1182/blood.2021013472. Acesso em: 7 ago. 2025.

GANZ, T. Anemia of inflammation. The New England Journal of Medicine, v. 381, p. 1148–1157, 2019. Disponível em: https://doi.org/10.1056/NEJMra1804281. Acesso em: 7 ago. 2025.

PASRICHA, S. R. et al. Iron deficiency. The Lancet, v. 397, p. 233–248, 2021. Disponível em: https://doi.org/10.1016/S0140-6736(20)32594-0. Acesso em: 7 ago. 2025.

WILLIAMS, A. M. et al. Changes in micronutrient and inflammation serum biomarker concentrations after a norovirus human challenge. American Journal of Clinical Nutrition, v. 110, p. 1456–1464, 2019. Disponível em: https://doi.org/10.1093/ajcn/nqz201. Acesso em: 7 ago. 2025.

THURNHAM, D. I. et al. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. American Journal of Clinical Nutrition, v. 92, p. 546–555, 2010. Disponível em: https://doi.org/10.3945/ajcn.2010.29284. Acesso em: 7 ago. 2025.

DARTON, T. C. et al. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Neglected Tropical Diseases, v. 9, e0004029, 2015. Disponível em: https://doi.org/10.1371/journal.pntd.0004029. Acesso em: 7 ago. 2025.

Publicado

2025-08-14

Cómo citar

DA SILVA, Laura Leme de Araujo Rodrigues et al. TRATAMIENTO DE LA ANEMIA FERROPÉNICA EN ADULTOS EN ATENCIÓN PRIMARIA: DE LA INVESTIGACIÓN AL TRATAMIENTO BASADO EN LA EVIDENCIA. LUMEN ET VIRTUS, [S. l.], v. 16, n. 51, p. e7305, 2025. DOI: 10.56238/levv16n51-039. Disponível em: https://periodicos.newsciencepubl.com/LEV/article/view/7305. Acesso em: 5 dec. 2025.